Admittance
Education
|
Bradley Mayhew is a licensed attorney and is registered
to practice before the U.S. Patent & Trademark Office.
His primary focus is the preparation and prosecution of patent applications
drawn to inventions in the areas of biotechnology, pharmacology
and chemistry.
Brad has significant work experience in the field of Intellectual
Property. Prior to founding
Mayhew Law,
Brad worked as a Patent Agent at the law firm of Sidley Austin Brown
& Wood, where he conducted research in support of patent litigation
as well as patent infringement and freedom-to-operate opinions.
Brad also worked as an Intellectual Property Manager at Medimmune
where he assessed the potential value and patentability of inventions,
coordinated with inventors and external counsel to direct patent
prosecution, and monitored competitive intellectual property developments.
In addition, Brad served for three years as a Patent Examiner at
the U.S. Patent & Trademark Office where he examined cases in the
area of complex biotechnology.
Brad has extensive knowledge of subjects relevant to the biotechnology
and pharmaceutical industries. He performed and published research
in the fields of enzymology and drug metabolism as a researcher
in the Department of Medicine at the Indiana University School of
Medicine. He also earned a graduate degree from the school's Department
of Pharmacology where his studies included courses in pharmacology,
physiology, medicinal chemistry, bio-organic chemistry, biophysics,
biochemistry and physical biochemistry. Brad additionally holds
an undergraduate degree in biology with an emphasis in molecular
genetics and a minor in chemistry.
Prior to graduate study, Brad worked in Japan as an editor in
the Research Planning Department of Sankyo Co., Ltd., a major Japanese
pharmaceutical company. His work involved editing and rewriting
manuscripts from diverse fields including chemistry, analytical
chemistry, biochemistry, pharmacology, toxicology and clinical medicine.
The experience provided a unique insight into the mechanisms for
research and development conducted in the pharmaceutical industry.
|
Prior Employment
|
| ◦ |
Sidley
Austin Brown & Wood LLP, Washington, DC
Patent Agent
|
| ◦ |
Medimmune, Inc., Gaithersburg, MD
Intellectual Property Manager
|
| ◦ |
U.S.
Patent & Trademark Office, Arlington, VA
Patent Examiner
|
| ◦ |
Indiana University School of Medicine, Indianapolis, IN
Research Analyst
|
| ◦ |
Sankyo Co., Ltd., Tokyo, Japan
Technical Editor
|
Memberships
|
| ◦ |
American Bar Association, Intellectual Property Law
(ABA-IPL) |
| ◦ |
American Intellectual Property Law Association
(AIPLA) |
| ◦ |
Association of University Technology Managers
(AUTM) |
| ◦ |
Patent & Trademark Office Society
(PTOS) |
| ◦ |
National Association of Patent Practitioners
(NAPP) |
| ◦ |
International Society for the Study of Xenobiotics
(ISSX) |
| ◦ |
Phi Delta Phi
(ΦΔΦ)
|
Publications
| ◦ |
Jones DR, Gorski JC, Hamman MA, Mayhew BS, Rider S, and Hall
SD
"Diltiazem Inhibition of CYP3A Activity is Due to Metabolite Intermediate
Complex Formation" Journal of Pharmacology and Experimental
Therapeutics, 1999, vol. 290, no. 3, pages 1116-1125 |
| ◦ |
Hall SD, Mayhew BS, Gorski JC, and Jones DR
"Principles of In Vitro Studies: Enzyme Kinetics, Inhibition and
Induction" in Drug-Drug Interactions: Analyzing In Vitro-In
Vivo Correlations, IBC USA, Inc., 1996 |
| ◦ |
Mayhew BS, Jones DR, Gorski JC, and Hall SD
"Non-Hyperbolic Interactions Between Substrates of Cytochrome P450
(CYP) 3A4" Midwest Cytochrome P450 Symposium, 1996 |
| ◦ |
Mayhew BS, Gorski JC, and Hall SD
"Midazolam Hydroxylation Reveals the Potential for Non-Hyperbolic
Kinetics in Cytochrome P450 (CYP) 3A4"
ISSX Proceedings, 1995, vol. 8, page 3 |
|
|